Hormone therapy for prostate cancer increases the risk of Alzheimer’s disease: a nationwide 4-year longitudinal cohort study
Hormone therapy for prostate cancer increases the risk of Alzheimer’s disease: a nationwide 4-year longitudinal cohort study
J. Jhan,Yuan-Han Yang,2 Authors,Chia-Chun Tsai
2017 · DOI: 10.1080/13685538.2016.1271782
The Aging Male · 36 Citations
TLDR
The present results suggest that ADT use is associated with an increased risk of developing Alzheimer’s disease, and the relationship between androgen depletion and dementia is not clear.